About the Authors

Aastha Gupta

aastha.gupta@tballiance.org

Affiliation TB Alliance, New York, NY, United States of America

Sandeep Juneja

Contributed equally to this work with: Sandeep Juneja, Suvanand Sahu, Mohammed Yassin, Grania Brigden, Eliud Wandwalo, Fuad Mirzayev, Matteo Zignol

Affiliation TB Alliance, New York, NY, United States of America

Suvanand Sahu

Contributed equally to this work with: Sandeep Juneja, Suvanand Sahu, Mohammed Yassin, Grania Brigden, Eliud Wandwalo, Fuad Mirzayev, Matteo Zignol

Affiliation Stop TB Partnership, Geneva, Switzerland

Mohammed Yassin

Contributed equally to this work with: Sandeep Juneja, Suvanand Sahu, Mohammed Yassin, Grania Brigden, Eliud Wandwalo, Fuad Mirzayev, Matteo Zignol

Affiliation The Global Fund, Geneva, Switzerland

Grania Brigden

Contributed equally to this work with: Sandeep Juneja, Suvanand Sahu, Mohammed Yassin, Grania Brigden, Eliud Wandwalo, Fuad Mirzayev, Matteo Zignol

Affiliation The Global Fund, Geneva, Switzerland

Eliud Wandwalo

Contributed equally to this work with: Sandeep Juneja, Suvanand Sahu, Mohammed Yassin, Grania Brigden, Eliud Wandwalo, Fuad Mirzayev, Matteo Zignol

Affiliation The Global Fund, Geneva, Switzerland

Saurabh Rane

Affiliation Survivors Against TB, Mumbai, India

Fuad Mirzayev

Contributed equally to this work with: Sandeep Juneja, Suvanand Sahu, Mohammed Yassin, Grania Brigden, Eliud Wandwalo, Fuad Mirzayev, Matteo Zignol

Affiliation World Health Organization, Geneva, Switzerland

Matteo Zignol

Contributed equally to this work with: Sandeep Juneja, Suvanand Sahu, Mohammed Yassin, Grania Brigden, Eliud Wandwalo, Fuad Mirzayev, Matteo Zignol

Affiliation World Health Organization, Geneva, Switzerland

Competing Interests

I have read the journal’s policy and the authors of this manuscript have the following competing interests: Aastha Gupta is a consultant to the Global Alliance for TB Drug Development (TB Alliance), a non-profit organization dedicated to the discovery and development of improved TB therapeutics. TB Alliance is funded by governments and foundations and developed pretomanid/BPaL. Sandeep Juneja is an employee of the Global Alliance for TB Drug Development (TB Alliance), a non-profit organization dedicated to the discovery and development of improved TB therapeutics. TB Alliance is funded by governments and foundations and developed pretomanid/BPaL.